The Bromodomain Inhibitor PFI-3 Sensitizes Cancer Cells to DNA Damage by Targeting SWI/SNF.

Molecular Cancer Research : MCR
Daye LeeJongbum Kwon

Abstract

Many chemotherapeutic drugs produce double-strand breaks (DSB) on cancer cell DNA, thereby inducing cell death. However, the DNA damage response (DDR) enables cancer cells to overcome DNA damage and escape cell death, often leading to therapeutic resistance and unsuccessful outcomes. It is therefore important to develop inhibitors that target DDR proteins to render cancer cells hypersensitive to DNA damage. Here, we investigated the applicability of PFI-3, a recently developed bromodomain inhibitor specifically targeting the SWI/SNF chromatin remodeler that functions to promote DSB repair, in cancer treatment. We verified that PFI-3 effectively blocks chromatin binding of its target bromodomains and dissociates the corresponding SWI/SNF proteins from chromatin. We then found that, while having little toxicity as a single agent, PFI-3 synergistically sensitizes several human cancer cell lines to DNA damage induced by chemotherapeutic drugs such as doxorubicin. This PFI-3 activity occurs only for the cancer cells that require SWI/SNF for DNA repair. Our mechanism studies show that PFI-3 exerts the DNA damage-sensitizing effect by directly blocking SWI/SNF's chromatin binding, which leads to defects in DSB repair and aberrations i...Continue Reading

References

Jun 20, 2001·Nature Reviews. Molecular Cell Biology·E A Nigg
Nov 14, 2008·Nature Reviews. Cancer·William M BonnerYves Pommier
Jun 9, 2009·DNA Repair·Simon N Powell, Ranjit S Bindra
Jun 16, 2009·Nature Cell Biology·Guang PengShiaw-Yih Lin
Sep 28, 2010·Nature·Panagis FilippakopoulosJames E Bradner
Nov 3, 2010·Advances in Cancer Research·Joanne SmithDavid A Gillespie
Nov 12, 2010·Nature·Edwige NicodemeAlexander Tarakhovsky
Jan 20, 2012·Nature·Christopher J Lord, Alan Ashworth
Sep 26, 2013·Nature Reviews. Cancer·Caitriona HolohanPatrick G Johnston
Apr 23, 2014·Nature Reviews. Drug Discovery·Panagis Filippakopoulos, Stefan Knapp
Sep 10, 2014·Cancer Cell·Katherine C HelmingCharles W M Roberts
Nov 12, 2014·Annual Review of Pathology·Julien Masliah-PlanchonOlivier Delattre
Feb 25, 2015·Nature Reviews. Cancer·Laurence H PearlFrances M G Pearl
Nov 18, 2015·Journal of Medicinal Chemistry·Frank Anthony RomeroSteven Magnuson
Feb 26, 2016·Journal of Medicinal Chemistry·Laetitia J MartinDarryl McConnell
Apr 27, 2016·Journal of Medicinal Chemistry·Brian S GerstenbergerDafydd R Owen
Dec 3, 2016·Epigenetics : Official Journal of the DNA Methylation Society·Montserrat Pérez-Salvia, Manel Esteller
Jan 6, 2017·Nature Reviews. Molecular Cell Biology·Takao Fujisawa, Panagis Filippakopoulos
Nov 25, 2017·MedChemComm·Moses MoustakimPaul E Brennan
Jan 10, 2019·ChemMedChem·Michael A CleggPhilip G Humphreys
Mar 22, 2019·DNA Repair·Cristina Ribeiro-SilvaHannes Lans
Jul 6, 2019·Nature Reviews. Drug Discovery·Andrea G CochranRobert J Sims
Aug 9, 2019·The EMBO Journal·Michael Charles LanzMarcus Bustamante Smolka
Oct 5, 2019·Nature Structural & Molecular Biology·Nilesh Zaware, Ming-Ming Zhou

❮ Previous
Next ❯

Citations

Jul 25, 2021·Cancers·Samuel P BoysonKaren C Glass

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.